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ABSTRACT
Previous research suggests that nucleus basalis
magnocellularis

(NBM)

lesions impair cognitive flexibility,

decrease positive transfer across behavioral problems, and
impair divided attention.

It is unclear,

however, whether

previously observed impairments were due to impaired complex

relational or "configural learning," or to an impaired

ability to learn conflicting response rules and apply them

appropriately as task conditions change.

In order to assess

flexibility in acquiring and using conflicting response
rules, rats with selective lesions of the■NBM or sham-lesion

controls, were subjected to serial reversal training in a

simple operant discrimination paradigm'.

In this paradigm,

rats were first food-reinforced for lever pressing in

response to a tone but not reinforced for responding to a
light.

After’ reaching criteria, reinforcement contingencies.

were reversed and training continued until criteria was
reached again.

Contingencies were reversed a total of four

times, with training continuing until criteria was reached,

followed by extinction training.

Based on the argument that the NBM is not involved in
simple association learning, it was hypothesized that
acquisition of the original discrimination would not be

impaired in the NBM lesion group as compared to controls.
iii

In

contrast, based on findings suggesting that damage to the

NBM causes perseveration or causes impairments in cognitive

flexibility, it was hypothesized that NBM lesions would

disrupt the ability to efficiently switch between

conflicting response rules.

Thus, the NBM lesion group was

predicted to make more commission errors and to require more

days to reach criteria on each successive reversal than
controls.

Immediately - following completion of the fourth

reversal, rats proceeded to an extinction phase.

Based on

the argument that NBM lesions would cause perseveration,

it

was expected that the NBM lesion group would extinguish

lever press behavior more slowly than controls..

That is,

when the contingency changed from reinforcement to non

reinforcement during extinction training, the NBM lesion
group was expected to continue to respond due to
difficulties changing behavior in response to changes in

reinforcement contingencies.
hypotheses.

Results confirm these

Groups did not differ during acquisition of the

original discrimination, but the NBM lesion group required
more days to reach criteria than controls on the first

reversal.

The NBM lesion group, however, demonstrated

behavioral recovery and subsequent reversal performance did
not differ between groups.

These results suggest that NBM

lesions produce an impairment in cognitive flexibility.
iv
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CHAPTER ONE
ALZHEIMER'S DISEASE

Introduction

(AD)

Alzheimer's disease

is characterized by a

degeneration of the cortically projecting cholinergic

neurons in the nucleus basalis of Meynert in humans
Kornecook, Bastianetto,

& Quirion, 2002; Braak & Braak,

1996; Chiba, Bucci, Holland,

1996; Jellinger,
Ferszt,

& Bancher,

& Cervos-Navarro,

& Gallagher,

1995; Crawley,

1998; Lowes-Hummel, Gertz,

1989; Muir,

1997; Nitsch,

Perl, 2000; Samuel, Terry, DeTeresa, Butters,
1994; Sarter & Bruno,

Clark, Coyle,
1998).

(Auld,

1999; Wenk,

1996;

& Masliah,

1997; Whitehouse,

& Delong, 1981; Winkler, Thai, Gage,

Price,
& Fisher,

This neurodegeneration leads to both a decreased

amount of the neurotransmitter acetylcholine

(ACh)

neocortex and decreased cognitive functioning.

in the

AD is the

leading cause of dementia in mid to late adult life,

leading

to memory loss, decline in ability to perform routine tasks,
disorientation, difficulty in learning,
skills,

loss of language

impairment of judgment and personality changes

(Alzheimer's Association; Auld et al., 2002; Wenk,

1997).

It is the significant loss of brain cells that ultimately

1

leads to body system failure and ultimately death

(Dickson,

2001) .

According to the Alzheimer's Association (www.alz.orq),
about 4.5 million Americans, suffer from AD.
national survey,

In a 1993

19 million Americans were found to have a

family member with AD, and 37 million knew someone with AD.

Another startling statistic is that 14 million Americans
will have AD by the middle of the next century unless a cure

or prevention is found.

AD is also an expensive disease to

treat, with the average lifetime cost being approximately

$174,000.

Cognitive Impairments in Alzheimer's Disease

The progression of AD usually follows a pattern,
beginning with memory dysfunction; the first signs of AD are

usually problems associated with memory.

Other

presentations of the disease include personality changes,

visuospatial disorientation, difficulty with language, and
even depression.

The disease process then leads to motor

problems until the patient is unable to get out of bed, no
longer speaks,

is incontinent, and becomes completely

disoriented (Braak et al., 1996; Dickson, 2001).
In the midst of other cognitive and physical changes,

memory impairments remain constant throughout the
2

progression of the disease
Raaijmakers,

(Eslinger & Damasio,

1986; Spaan,

Patients with AD suffer a

& Jonker, 2003).

myriad of memory impairments which include difficulty with
free recall

Cox,

(Eslinger & Damasio, 1986; Martin, Brouwers,

& Fedio,

& Kaszniak,

1985), cued recall

1991; Chertkow & Bub,

Reminger, Rinaldi, Wilson,
Spinnler,

1994),

(Dudas, Berrior,

(Bird & Luszcz,

1991; Bondi

1990; Monti, Gabrieli,

& Fleischman,

1996; Russo &

as well as impaired recognition memory

& Hodges, • 2005; Eslinger & Damasio,

1986).

Memory impairments usually affect one's ability to

learn new things.
spared in AD.

However, certain types, of learning are

Eslinger and Damasio (1986)

compared AD

patients with controls on motor, verbal, and visual learning

tasks and found that despite difficulty in learning both

verbal and nonverbal information, AD patients were able to

learn motor activities that required procedural memory.
Procedural memory or skill learning, involves implicit

memory.

This type of memory involves multiple cognitive

functions as well as motor skills to practice the new skill
until it becomes habit.

If procedural memory is intact, the

individual can improve his or her performance of the task on
subsequent trials.

This is in contrast to declarative

memory or knowledge which is dependent on memory which may
be context specific and relate to specific experiences with

3

objects or places

(e.g.

facts, or events). Declarative

memory, which involves memory of sensory experiences and is
usually contextual, can be further divided into episodic and
semantic memory (Eslinger & Damasio,

1986).

Semantic memory

refers to facts and general knowledge while episodic memory
refers to our experiences.

-Impairments in both of these

types of memory can be found in early stages of AD (Dudas et

In the same study, during

al., 2005; Spaan et al., 2003).

the motor learning task, which required procedural memory,

AD patients were initially impaired but improved with
subsequent trials. However, the AD group failed to learn
both the verbal and visual learning tasks which were

examples of tasks that required declarative memory.

According to Dudas et al.

(2005), at this early stage

of the disease the patient is customarily diagnosed with
mild cognitive impairment

(MCI).

Dudas et al.

(2005)

found

that patients with MCI as well as those with AD, show signs
of episodic and semantic memory loss.

Approximately 15-20%

of patients diagnosed with MCI are diagnosed with AD-within
a 2 year period of their initial diagnosis.

Consequently,

because of the increased risk of a person diagnosed with MCI
to be later diagnosed as having AD, early’ detection of these

impairments is critical.-

4

These types of cognitive impairments are usually the
first to be reported and are common even before the patient
is presumed to have AD.

recall,

Impairments in free recall,

cued

and recognition are all examples of episodic memory

impairments.

According to Spaan et al.,

(2003), this

suggests that individuals with AD experience a general

episodic memory impairmentt

Others argue that instead of a

general episodic memory impairment, it is faulty encoding
that prompts the learning impairments seen in AD (Greene,

Baddeley,

& Hodges 1996).

Still, others argue that episodic

memory is dependent on semantic memory (Dudas et al.,

2005).

Another type of memory impairment in AD patients
involves working memory or memory span.

colleagues

(2000)

Rochon and

compared performance of AD patients with .

age matched controls on a series of working memory tests and
sentence comprehension.

AD patients were found to have

reduced memory spans compared to controls as well as
difficulty with sentence comprehension.

Additionally, there

is evidence suggesting a visuospatial working memory

impairment in patients with AD (Trojano, Chiacchio, De Luca,
& Grossi,

1994).

Johnstone et al.

(2002) have provided a profile of the

neuropsychological deficit seen in AD dementia.

In

evaluating the.degree of deficit, the authors examined five

5

areas of performance in cognition and compared them to an

estimate of premorbid intelligence in order to calculate the
relative degree of decline.

The five areas examined were:

intelligence, memory, attention, speed of processing and
cognitive flexibility.

Subjects were given various

standardized tests such as the Wechsler Adult Intelligence
Scale-Revised

(WAIS-R), the Wechsler Memory Scale-Revised

(WMS-R), the Wide Range Achievement Test-Revised (WRAT-R),

the Reading Subject Test and the Trail Making Tests.
Results of this study indicate that speed of processing and

cognitive flexibility suffered the most in AD patients.

Perseveration in Alzheimer's Disease

Bigler et al.

(1988) note that AD patients have

difficulty changing behavior in the face of changes in

reinforcement contingencies.

perseveration.

This is what is referred to as

Although there are different types of

perseveration, perseveration generally reveals itself as
inappropriate persistent responding such that the person or

animal repeats or fails to inhibit a previous response
(Bayles, Tomoeda, McKnight, Helm-Estabrooks,
Galdi,

& Hawley 2004;

1993). Normal humans treated with drugs that

interfere with the neurotransmitter ACh show perseveration,
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suggesting a link between cholinergic dysfunction and

perseverative behavior

(Bigler et al.,

1988).

Patients with AD show signs of verbal and nonverbal

perseverations.

These examples of cognitive inflexibility

or rigidity have been further divided into more specific
types of perseveration such as continuous, recurrent,

substitution,

and stuck-in-set perseveration

2004; Ryan, McGowan, McCaffrey, Ryan,

1995; Lamar., Carew, Resh, Goldberg,

Zandi,

(Bayles et al.,

& Brannigan,

Podell,

& Cloud e't al.,

1997; Caccappolo-van Vliet, .Miozzo, Marder,

& Stern, 2003).

Continuous perseveration refers to the act of continuing to

respond in the same manner without any interruptions.
Recurrent perseveration is responding to a new stimulus asif it were the previous stimulus.

Substitution

perseveration refers to replacing one object or element of a
✓ •
task with another.
Finally, -stuck-in-set perseveration
refers to the inability to shift- -from one method of

responding to another.
Lamar' et al. ,

(Caccappolo-van Vliet et al.,

2003;.

1997; McNamara & Albert, 2004; Ryan et'al.,

1995; Sandson & Albert, 1984).

, .

.

In a case study and review of perseveration,

Caccappolo-van Vliet et al.

(2003-)

discussed the hypothesis

that damage to specific brain areas result, in specific types
of perseveration.

This hypothesis had previously been
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supported by Sandson and Albert

(1984) who found that stuck-

in-set perseverations were a result of frontal lobe damage.
The subject in the Caccappolo-van Vliet et al's.

(2003)

study exhibited continuous perseverations which have

previously been attributed to an impairment in attention.
However, Caccappolo-van Vliet and colleagues

(2003) do not

attribute their subject's perseverations to a general

impairment in attention because the perseverations were only
limited to writing.

In contrast, perseverations that are

due to an impairment in attention usually result in

perseverative errors in a wide assortment of tasks.
In a study of AD patients and verbal perseveration

(Bayles et al., 2004), a significant relationship was found

between results of attention and memory tests, mental status
and task type.

The patterns and amount of verbal

perseverations observed in the AD patients depend on type of
test, mental status, attention or memory tests.

al.

Bayles et

(2004) hypothesized that AD patents would perseverate

more than controls on language tests and that the amount of

perseveration would vary according to type of language test,
mental status, and performance on various attention and
memory tests.

Subjects were given two of three different

language tests which were all a variation of a naming test
(Confrontation Naming, Generative Naming, and Picture

8

Description).

Mental status was measured’ using the Mini-

Mental State Exam (MMSE).

Attention and memory tests

included the Modified Wisconsin Card Sort, the Wechsler

Memory-Scale-Revised and the Arizona Battery for
Communication Disorders, in Dementia.
Overall, Bayles et al.

(2004)

found that AD patients

did indeed perseverate more than controls.

However, the

amount of perseveration varied according to task type, with
significant differences found between groups on the

Generative Naming test.

Puzzlingly, a positive correlation

was found between mental status and amount of perseveration

on the Generative Naming test; with relatively better mental
status, AD patients tended to perseverate more on this task.

The other two language tests were negatively correlated with
amount of perseveration.

According to Bayles et al.

(2004), results of this

study are more complex than might first be apparent.
Considering that mental status and cognitive impairment, in

terms of amount of perseveration, do not necessarily follow
a linear .pattern, a more complex argument must be

investigated.

Bayles et al.

(2004)

suggest that the varying

results of this study may reflect differences in the

relative cognitive demand linked to each assessment

instrument.

It may be that the absence of perseveration is

9

a result of too difficult a task, meaning that if the

patient could have done the task then perseverative behavior
might have been witnessed.
Alzheimer's disease is not the only form of dementia
that results in perseverative behavior.
from ischemic vascular dementia

perseveration.

(IVD)

Patients suffering

also show signs of

However, the patterns and types of

perseverations vary according to the type of dementia

et al.,

1997).

(Lamar

One theory to explain these differences

involves a ranking of cognitive disorders that are related
to different types of perseveration.

What this means is

that higher level cognitive disorders lead to perseverations
of higher order semantic functions and lower level cognitive

disorders are related to perseverations of lower level
functions such as motor behaviors

Goldberg,
colleagues

1986) .

(Lamar et al.,

1997;

This hypothesis is supported by Lamar and

(1997) who compared perseverative behavior of AD

patients with IVD patients.

In'this study, perseverations

made by AD patients were of a higher order cognitive nature

whereas IVD patients made more motor related perseverations.

Ryan et al.

(1995)

of Alzheimer's patients.

examined perseveration in a group

Specifically,

they studied

"wandering," a type of nonverbal perseveration, which is
defined by increased motor activity and frequent
10

disorientation in familiar places.

It'was predicted that .AD

patients with wandering behavior would be more likely to

perseverate on a series of cognitive tasks

(e.g.,' Bender

Visual Motor Gestalt, the Clock Drawing Test, and the
Attention/Concentration Index taken from the WMS-R)

to AD patients without wandering .behavior.

compared

Dependent

measures were type and amount of perseveration,

attention/concentration, and spatial orientation for each of

the following tasks.

The.Bender Visual Motor Gestalt

identified three types of perseveration: 1)
perseveration,

2)

continuous

recurrent perseveration, and 3)

substitution perseveration-.

Results indicate that AD patients that exhibited
I
"wandering" behavior were more likely to also display

recurrent and continuous perseverations in the Bender Visual
Motor Gestalt test when compared to non-wandering AD
■f
__
patients.
AD patients with "wandering" behavior that were

also identified as having multi-in'farct dementia were more

likely to show substition perseverations.

Substitution

perseverations are believed to be linked to encephalopathy,

and frontal or frontotemporal damage.

Continuous '

perseverations are said to be linked to right hemispheric

damage, which may result in. impairments in attention and
even locomotor activity.

Surprisingly, there were no

11

significant differences in visuospatial skills between .

wanderers and patients who did not show signs of wandering

behavior.

Ryan et al.

(1995)

suggest that the link between

visuospatial skills and wandering behavior may not be

clearly evident until the mid to late stages of AD.

12

CHAPTER TWO

NEUROANATOMY AND NEUROPATHOLOGY

Introduction
Classification of AD is a combination of both

macroscopic and microscopic changes.

primarily involve cerebral atrophy.

Macroscopic changes
Microscopic changes

include neurofibrillary tangles, senile plaques,

congophilic

angiopathy, granulovacuolar bodies, hirano bodies,

synaptic loss

(Perl, 2000).

and

Postmortem evaluation of AD

brains reveals dilated lateral ventricles and atrophy of the
hippocampus and amygdala.

Other changes include loss of,

pigment to the locus ceruleus,-loss of large pyramidal
neurons in the cortex,

significant synaptic damage, amyloid

plaques, 'neurofibrillary tangles and neurophil threads.

Granulovacuolar degeneration and Hirano bodies are also

found in AD brains, as well as normal brains, much to a

greater degree.

Research has also been able to link

cognitive impairment with the amount of granulovacuolar
damage as well as neurofibrillary tangles, neurophil

threads, and extent of synaptic injury (Dickson, 2001).
Various organizations have also identified criteria by

which AD can be identified.

These criteria include a scale

based on number of senile plaques, density of senile

13

plaques, as well as an evaluation of extent of damage by
neurofibrillary tangles in conjunction with Braak and Braak
stages

(Perl,

2000) .

According to Jellinger et al.

(1998), in order to

receive' a diagnosis of AD, postmortem examination of the

brain looks for the presence of the following: atrophy of

the cerebral cortex, neuritic plaques, neurofibrillary

tangles, neurophil threads, paired helical filaments,
amyloid plaques and angiopathy.

There is also damage to

cortical connections that ultimately lead to the symptoms of

dementia.

It is these interruptions in synaptic connections

that are most responsible for cognitive deterioration seen

in AD.

There are also many statistical analyses that can be
done to evaluate the relationship between physical findings

and cognitive impairments. For example, examination of
postmortem AD brains found that synaptic density in the
midfrontal cortex was a predictor of cognitive impairment

(Samuel et al.,

1994).

There are also various cognitive

tests such as the Mini-Mental state or criteria to determine

the stages of AD.

Other statistically reliable analyses

take into consideration the number of neurofibrillary
tangles in the association neocortex (Dickson, 2001;

14

Doucette, Fisman-, Hachinski,
al.,

& Mersky,

1986; Jellinger et

1998) .
To summarize, Alzheimer's disease . (AD)

is characterized

by specific neuropathology that includes amyloid plaques and

neurofibrillary tangles throughout .the neocortex, and

significant cholinergic neuron death in the nucleus basalis
of Meynert

(AUld et al., 2002; Cummings,

1986; Ezrin-Waters & Resch,

1999; Jellinger et al.,
Greig, Giacobini,

& Schneider, 2003;.Mann,

Bruno,

& Mirra,

Sambamurti,

1985; Pearson,

1985; Pepeu et al.,

1985; Samuel et al.,

1999; Strada et al.,

&

1986; Francis et al.,

1998; Lahiri, Farlow,

Esiri, Hiorns, Wilcock & Powell,

Rogers, Brogan,

1998;

1986; Etienne, Robitaille, Gauthier,

Doucette et al.,
Nair,

& Back,

1994;

1994; Sarter &

1992; Winkler et al.,

1998).

Each of these major forms of neuropathology will be revealed

below.

Amyloid Plaques and Neurofibrillary 'Tangles
According to Braak and Braak (1996)

amyloid deposits

form before the formation of neurofibrillary tangles

(NFT).

The presence of both features-is representative'of later ■
stages of AD.

Neurofibrillary changes usually affect the

hemispheres in a symmetrical fashion but neuritic plaques,

such as beta amyloid (A3) plaques, are not usually found in
15

a uniform distribution.

Other lesions found in AD brains

include neurophil threads in the cortex, where their
densities are usually correlated with NFT’ density.

NFT's are intracellular structures that are made up of
filaments that consist of a microtubule-associated protein,
tau.

The amount of NFT throughout the brain in areas

including the cortex, temporal neocortex, and
parahippocampal gyrus, has been correlated with the extent

of cognitive impairments found in AD (Lahiri et al., 2003;
NFT measures have been found to be better

Larner, 2002).

predictors of cognitive deficits than A(3 plaques.
result,

As a

inhibition of tau represents a possible intervention

for AD patients.

Drugs that work on tau have two main foci,

either to block the hyperphosphorylation of tau or to

inhibit the kinase that phosphorylates tau (Larner, 2002).
There is evidence demonstrating a genetic component to
the abnormal amyloid protein responsible for amyloid plaque

accumulation in AD.

AD, Cutler et al.,

In a review of AD and the treatments of
(2001) noted that as much as 30-50% of AD

cases could be linked to genes.

For instance, mutations of

amyloid precursor protein (APP) have been associated with

familial AD.

Research has suggested that APP is a

significant factor in the pathology of AD (Cutler et al.,

2001; Lahiri et al.,

2003).

Specific genes of APP,
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pr.esenilin 1

(PS-1) and presenilin 2

(PS-2), have been

suggested to be responsible for familial AD‘as well as the

production of amyloid plaques, thus leading to an amyloid
hypothesis of AD..

As a result, much of AD research has

focused on the inhibition of A(3 production.

hypothesis,

To study this

researchers have created transgenic mice that

carry mutated forms of the human APP genes.
production Involves various secretases,

Because A(3

specifically a, (3

and ysecretase, it is logical that research in this area

has focused on the enzymes that act on APP and thereby
result in

the production of A3 plaques.

PS-1 knockout

mice have shown a prominent decrease in y-secretase activity

but no change in activity of the other two secretases.
Thus, y-secretase activity has recently developed a

significant amount of attention

(Larner, 2002).

The release of APP has also been found to be activity-

dependent.

This was confirmed by generating action

potentials in rat brain tissue slices, which increased the
release of various neurotransmitters.

Electrical

depolarization then resulted in the release of APP's but not

other proteins subsequently eliminating the possibility that
the increase of APP's was due to other factors,

leakage.

such as

Further research also suggests that APP's have

neuroprotective properties related to learning and memory,
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but this hypothesis calls for additional research..

In

contrast, research in genetics has found that APP's are
involved in the production of A3 peptides, which are

neurotoxic.

AD brains have also been found to have a

greater number of receptors for A3 peptides than controls
(Dickson, 2001; Nitsch,

1996).

Potential treatments to suppress production of amyloid

plaques involve the use of muscarinic ml receptor agonists.
Preliminary studies have found that muscarinic agonists have

the ability to impede the progression of APP's as well as
delay the disease process of AD and improve attention.

The

potential ability for muscarinic agonists to increase levels
of. APP derivatives,

such as p3, and its impact on the

progression of AD is still under investigation

(Nitsch,

1996) .

Another target of treatment of AD is A3 neurotoxicity.
Treatment such as vitamin E and other antioxidants have had

some success in delaying the progression of AD.

Other

treatment strategies have focused on researching a possible
AD vaccine.

This vaccine consists of A3 antibodies and has

successfully decreased the amount of A3 plaques

2002).
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(Larner,

Cholinergic Hypofunction in Alzheimer's Disease

Another important finding associated with AD is the
significant neuronal loss in the nucleus basalis of Meynert

(nbM). This loss of neurons is indicative of the damage to

the basal forebrain cholinergic system and has shown to be
correlated with the severity of cognitive deficits
al., 2002; Cummings et al.,

Etienne et al.,
al.,

Mann,

1999; Gold,

1986;

1986; Ezrin-Waters et al.,1986;. Francis et
2003; Jellinger et al.,

1985; Pepeu et al.,

et al.,

1998; Doucette et al.,

(Auld et

1998; Larner, 2002;

1994; Rogers et al.,

1994; Strada et al.,

1992; Wenk,

1985; Samuel

1997; Winkler et

al. , 1998) .
Another important characteristic of the nbM is related

to its location in the brain.
basal forebrain,

The nbM is located in the

specifically in the substantia innominata

(Ezrin-Waters et al.,

1986; Wenk,

1997).

The nbM is

centrally located between the structures of the limbic
system and the neocortex. In addition to providing the
cortex with ACh, the nbM also receives input from the limbic

system and then relays information to the neocortex.

This

anatomical evidence may provide insight to some of the
psychiatric symptoms of AD (Auld et al., 2002; Cummings et
al., 1998) .
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The neurons of the nbM project to many areas of the
brain including the hypothalamus, amygdala and. the cortex.
As previously mentioned, the significant cell loss in the

nbM affects a number of neurotransmitter systems.

The

cortical projections of the nbM are the most relevant to
this study because they supply the cortex with ACh and a
substantial loss of cortical ACh is another common feature
of AD patients

1999).

(Ezrin-Waters et al.,

1986; Francis et al.,

This decrease in cortical ACh in AD patients has led

to the development of the cholinergic hypothesis- of AD.

This hypothesis suggests that the cognitive dysfunction
found in AD can be attributed to the loss of neurons in the

nbM which results in less ACh distributed to the cortex
(Auld et al., 2002; Bartus, 2000; Cummings et al.,

Lahiri et al., 2003; Sarter,

Additionally,

1998;

1994; Terry et al. 2003).

support for this hypothesis is that the

current and most effective treatments for AD are cholinergic
drugs

(Auld et al., 2002; Cutler et al., 2001).
Samuel et al.

(1994) examined plaques, neurofibrillary

tangles, neuronal and synaptic density in the nucleus

basalis of. Meynert

(nbM) of probable Alzheimer's disease

(AD) patients postmortem.

Participants in this study also

underwent extensive neuropsychological tests prior to death.
Tests included the Blessed Information-Memory-Concentration
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(IMC), the Mini-Mental State Examination (MMSE), and the

Dementia Rating Scale

Severity of dementia was

(DRS).

correlated with the degree of neuropathology in cortical and

subcortical brain regions, especially in the nbM.- Results
of this study suggest that two important contributors to

dementia found in AD patients.

Samuel et al.

(1994)

found

that diminishing synaptic- density in the midfrontal cortex

was highly correlated with severity of dementia.

In the .

nbM, -neurofibrillary tangles were found to be most
predictive of dementia, correlating significantly with
degree of cognitive impairment.

Doucette and colleagues

(1986)

found significant

differences in neuronal loss in the nbM related to severity

of AD dementia.
impairments,

Dementia

Patients who exhibited severe cognitive

as determined by the Extended Scale for

(ESD) , also possessed a greater degree of neuronal

loss in the intermediate and posterior regions of the nbM
compared to AD patients with less severe cognitive
dysfunction.

Other studies have demonstrated severe nbM

cell loss via postmortem evaluation of AD brains where there

can be as much as 90% cell loss in the nbM (Doucette et al.,

1986; Ezrin-Waters et al., 1986;).
McGeer et al.

(1984)

evaluated age-related changes in

the nbM and found cholinergic cell counts as low as 45,50021

100,500 in AD brains compared to 140,000 in non-AD brains of
human subjects 80 years of older.

These changes are

remarkable when compared to younger controls in the study

who had as much as 400,000-475,000 cholinergic cells.in the
nbM.

Additionally, age-dependent neuronal loss in the nbM

has been found in humans

(Lowes-Hummel et al., 1989).

Further evidence suggesting a connection'between the

cholinergic system and the disease process of AD involves
choline acetyltransferase

(ChAT).

A significant loss of nbM

neurons results in decreased ChAT activity.

Previous

research has found that pre-mortem mental test scores of AD

patients is associated with ChAT'activity.

Reductions in

ChAT activity in AD patients can be quite dramatic.

For

example, previous biochemical research has found 30-90%
region specific reductions in ChAT activity.

As much as a

50% decrease in mRNA ChAT activity has also been found in
the frontal, parietal, and temporal cortices' of AD patients.
Other related factors include high affinity choline uptake
(HACU), ACh release and both nicotinic and muscarinic ACh

receptor binding.

Later stages of AD,

and therefore severe

cognitive deficits, are also associated with severe
decreases in CHAT activity (Auld et al.,

2002).

Damage to the cholinergic neurons of the basal

forebrain of AD' patients not only affects ChAT activity and
22

There is a

ACh release but it also affects cognition.

substantial amount of evidence to support a relationship
between cognitive processes and the cholinergic system.

For

example, cortical ACh has been shown to be associated with
various forms of attention as well as learning and memory
(Gold, 2003; Sarter,

& Bruno, 1994; Sarter,

Sarter, Bruno & Givens, 2003).

& Bruno,

1999;

Attention related problems

such as increased response latencies, decreased response

accuracy, impairments in perceiving information and divided
attention are found in patients diagnosed with senile

dementia

(Sarter,

1994) .

Sarter (1994; Sarter,

& Bruno,

1999)

suggest that ACh

plays a major role in the processing of stimuli.
example,

For

research has shown that corticopetal cholinergic

projections, and therefore ACh,

is involved in the

detection, selection, and processing of various stimuli as
well as associations

Turchi,

1999) .

(Sarter & Bruno,

1999; Sarter, Bruno,

Additionally, previous research has found

strong correlations between the degree of cortical
cholinergic neuron damage and the ability to detect, select

and process behaviorally relevant stimuli.

Studies

involving humans and muscarinic antagonists,
scopolamine,

also support this hypothesis

1999).
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such as

(Sarter & Bruno,

&

Other psychiatric disorders marked by cognitive

impairments also possess features of a dysfunctional
cholinergic system.

According to the cholinergic

hypothesis, the cognitive symptoms of AD and other dementias
may be due in part to cholinergic hypofunction and

additionally cholinergic hypofunction may trigger the
cognitive deficits found in schizophrenia
Sarter and Bruno

(Sarter,

1994).

(1999) also suggest that .the cumulative

effects of inappropriate processing by the cholinergic

system leads to the attentional impairments seen in many

neuropsychiatric disorders.
ACh has been shown to possess a significant role in
processing throughout the sensory,' somatosensory, and

associational areas of the cortex.

In the visual cortex,

research has revealed that ACh assists neurons in their

ability to respond to visual stimulation as well as process
visual information.

Evidence comes from an increase in

responsivity of cortical neurons that stem from the lateral

geniculate nucleus as well as animal lesion studies.

Lesions of the basal forebrain resulted in decreased
responsivity to visual stimulation.

In humans,

administration of muscarinic receptor antagonists such as

scopolamine resulted in decreased ability to perform
visuospatial tasks such as line orientation.
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In addition,

patients suffering from senile dementia also display visual
impairments possibly related to loss of cortical cholinergic

inputs to the visual cortex.

In the auditory cortex, ACh

increases the activation of neurons.

This ACh evoked

increase in activation is hypothesized to ease the

recognition and discrimination of tones

(Sarter,

& Bruno,

1997).

Studies involving administration of cholinesterase
inhibitors have also yielded significant results in sensory
cortices.

These drugs have demonstrated the influence of

ACh on receptive fields of cortical sensory neurons as well

as the ability of ACh to alter neuronal responding.

As

previously shown in the auditory cortex, ACh is also
responsible for increases in activation of neurons in the
somatosensory cortex

(Sarter & Bruno, 1997), as well as

changes in the reactivity of cortical neurons
1994).

(Sarter,

Specifically, research shows that ACh is involved in

sensory plasticity.

For example, ACh'has been found to be

involved in the organization as well as changes to the -

receptive fields of the somatosensory cortex (Sarter,

Sarter & Bruno,

1997).

According to Sarter

1994;

(1994), these

changes take place as a result of ACh's ability to assist in

the processing of stimuli deep within the somatosensory
cortex.

These changes are reflected as enduring yet
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adaptable changes

(Sarter,

& Bruno,

1997) . Additional

evidence of the influence of ACh on neuronal plasticity will
be discussed later.

One hypothesis is that the role of ACh,
processing of relevant stimuli,

concept of attention.

in regards to.,

is related to the cognitive

Previous research suggests that

changes in cortical ACh release■are related to level of

cognitive demand or required.attention.

Thus,

cholinergic

cell loss results in cognitive impairments affecting
attention (Sarter,

& Bruno, .1997).

However,

it should be

noted that ACh is not tlhe only neurotransmitter that may be
involved in this aspect of cognition.

Other Neurotransmitter- System Involvement

Other neurotransmitter systems interact with the
cholinergic system, including the Y_Amino butyric acid
(GABA)

system.

The GABA system is closely linked to the

cholinergic system and therefore is also important to the

study of AD.

Cholinergic neurons of the basal forebrain

receive GABAergic input from the nucleus accumbens

Bruno,
2000).

1994; Sarter, Bruno,

& Turchi,

(Sarter &

1999; Sarter & Bruno,

GABA afferents have also been implicated in changes

in cortical ACh efflux, based on their connections to

cholinergic neurons of the basal forebrain.
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Previous

research has revealed a negative correlation between basal

forebrain GABAergic transmission and cortical ACh release.

Thus, decreases in GABAergic transmission lead to enhanced
cognitive functioning via increases in cortical ACh

& Bruno,

(Sarter

1994).

Benzodiazepine-receptor

(BZR)

agonists and inverse

agonists have proved to be quite useful in studying transsynaptic modulation.
by Sarter and Bruno

Trans-synaptic modulation, as defined
(1994),- refers to the "effects of

manipulations of the activity of an afferent neuronal system

on the excitability of its target neurons."
this technique has allowed researchers,

For example,

such as Sarter and

Bruno, to study the effects of GABAergic modulation on
cortical ACh.

Much of the research contains contradictory

results, however, the use of these agents has revealed the

importance of the level of activity in the cortical
cholinergic projections.

Such that they can be used to

modify cortical ACh to further focus the study of the role
of ACh in behavioral and cognitive processes
Bruno,

1994).

(Sarter,

&

BZR agonists and inverse agonists have

produced significant effects in attention.

Specifically,

infusions of BZR agonists have resulted in impairments in

sustained and divided attention in a similar fashion as
cholinergic antagonists

(Sarter, 1994; Sarter, Bruno,
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&

Turchi,

1999).

These impairments manifest themselves

during stimulus detection and discrimination thereby

interfering with previously learned associations
Bruno,

& Turchi,

1999).

(Sarter,

Both BZR agonists and BZR inverse

agonists affect cortical ACh efflux and this ability is
dependent on the activity of the cortical ACh afferents.

For example, BZR agonists decrease cortical ACh efflux while

BZR inverse agonists can increase cortical ACh release.
These findings as well as future research involving BZR

ligands may pave the way for a deeper understanding of the
functions of ACh (Sarter & Bruno,

1994).

Collectively, the

research on GABAergic modulation of cortical ACh release has
suggested further avenues for developing potential

pharmacological therapies for Alzheimer's disease,
addition to the current emphasis in modulating the
cholinergic system more directly.
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CHAPTER THREE

CLINICAL PHARMACOLOGY

Introduction

Sarter et al.

(1996)

reviewed research involving the

neuronal mechanisms for determining drug effects on
cognition.

Specifically, this paper examined drug-induced

cognition enhancement and what this means for the future of
pharmacology.

Cognitive psychopharmacology has recently

gained interest in attentional functions in cognition.

This

new direction is a result of pharmacological research that

has discovered that certain drugs that are known to produce

effects on learning and memory can also, have an effect on
attentional functions.

There is also additional evidence

that claims attentional impairments have a role in the

intensification of cognitive disorders such as dementia.
Therefore,

it is logical to develop drugs that enhance

cognitive functioning as a means of treatment.

The cholinergic system and its involvement in attention
has been a key focal point for neuropharmacological
research.

Lesion studies involving this system have led to

the conclusion that an intact cholinergic system is
necessary to provide optimal attentional functioning.

on the cholinergic hypothesis of AD, which argues that
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Based

cognitive impairment is the result of cholinergic

hypofunction, cholinesterase inhibitors are- currently used
in the treatment of AD.

Their use is based on the objective

of enhancing cholinergic neurotransmission through blocking

(Akasofu et al., 2003Barnes et al.,

the breakdown of ACh

2000; Liston" et al., 2004; Grossberg, 2003; Richter et al.,

2002; Schatzberg et al., 2001).
There are two major cholinesterases that work to
breakdown ACh-acetylcholinesterase

butyrylcholinesterase

(BuChE).

(AChE)

and

BuChE is a cholinesterase

associated with glial cells that represents about 10% of
cholinesterase activity in the temporal cortex of a normal

human brain.

However, in AD, BuChE activity increases as

the disease advances while AChE .activity decreases.
Therefore, the inhibition of BuChE as well as AChE may prove

to be an important factor in the treatment of AD patients to

the extent that these treatments prevent the degradation of
existing ACh (Grossberg, 2003; Liston et al., 2004).

However, the exact mechanism of BuChE is still a mystery.
Liston et al.

(2004)

also note that inhibition of BuChE and

AChE may be dangerous.

They cite research using AChE

knockout mice, which are highly sensitive to

BuChE

inhibitors and suggest that such dual inhibition may be

lethal.
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Drug Treatments

Cholinesterase

(ChE)

inhibitors have reliably been able

to treat the cognitive and functional problems associated
with AD (Liston et al. ,

2004; Rocca et al. , 2002).

There

are three ChE inhibitors that are currently most often
prescribed for AD.

They are donepezil, galantamine, and

A fourth drug, tacrine, was previously used

rivastigmine.

in the treatment of AD, but due to a high occurrence of

heptotoxicity it is no longer used (Grossberg, 2003; Rocca
et al., 2002) .
Donepezil

.
(Aricept®)

is a piperdine-based compound

approved by the U.S Food and Drug Administration for the

treatment of AD in 1997
al., 2001).

(Richter et al.,

2002; Schatzberg et

Donepezil selectively inhibits AChE

al., 2000; Diaz,

1999).

Donepezil is metabolized in the

liver by the cytochrome P450

active metabolites

(Barnes et

(CYP450)

(Diaz, 1999) .

system and has .two

It also has a long half-

life (approximately 70 hours) compared to the other ChE
inhibitors.

Donepezil also possesses a high affinity with

plasma proteins

(approximately 96% protein bound).

What

this means is that this drug may interfere with other highly

protein bound drugs taken at the same time (Diaz,
Grossberg, 2003, Rocca et al.,
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2002).

1999;

Rivastigmine is not only an AChE inhibitor but it also
inhibits BuChE.

Rivastigmine is primarily metabolized by

AChE and BuChE.

Thus, rivastigmine is unlikely to interact

with drugs that are metabolized by the CYP450 system.

also has a short half-life

It

(approximately 1-2 hours)

compared to the other approved ChE inhibitors.

Previous

research shows that cognitive improvements related to

rivastigimine are correlated with the inhibition of AChE■and

BuChE in AD patients

(Grossberg, 2003).

Galantamine is a selective competitive AChE inhibitor.

In animal studies, galantamine was able to increase ACh by
37% in the cortex (Barnes et al., 2000). Galantamine is

metabolized by the CYP450 system.

half-life

(approximately 6 hours)

shorter than donepezil

Galantamine has a longer
than rivastigmine but

(Grossberg, 2003; Rocca et al.,

2002).

Side Effects

Due to the common mechanism of action of the ChE
inhibitors, they share common side effects.

For instance,

the most common side effects include nausea, headache,
diarrhea,
fatigue,

insomnia, dizziness, muscle cramps, vomiting,

anorexia, depression, abnormal dreams, weight loss,

extrapyramidal symptoms and frequent urination.

The

exception is rivastigmine, which has a low incidence of the
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aforementioned side effects

(Grossberg, 2003, Liston et al.,

2004). This difference is thought to be associated with

rivastigmine's favored affinity for the G1 globular form of

AChE instead of G4.

The G4 form is found at the presynaptic

membrane of the skeletal neuromuscular junction.

Thus, ChE

inhibitors that bind to the G4 form may be related to
symptoms such as muscle cramps and weakness.
In a 6-month comparison of side effects between

donepezil and rivastigmine, it was found that donepezil had

significantly more adverse reactions
contrast, Liston et al.,

(Grossberg,

2003).

In

(2004)found that the more selective

AChE inhibitors resulted in fewer peripheral side effects

than the nonselective ChE inhibitors.

Liston et al.,

(2004)

also argue that rivastigmine's mechanism of action is

associated with a reduced therapeutic index as well as a
greater occurrence of cholinergic side effects.
Recent studies have linked two of the ChE inhibitors
with sleep dysfunction.

Donepezil and galantamine

treatment may reduce rapid eye movement latency leading to
decreased slow-wave sleep. Insomnia was observed most
frequently the highest in patients treated with.donepezil.

However, rivastigmine did not change REM latency and showed

the least disturbance in brain stem functions associated
with sleep (Grossberg, 2003)-.
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Dosing is also related to adverse effects of the ChE

inhibitors.

Current practice of administration with the

ChE's is a slow dose escalation.

Clinical studies with all

three ChE inhibitors have shown that a slow dose escalation
reduces the number of adverse effects and increases
tolerability (Diaz, 1999; Grossberg, 2003).

Efficacy and Tolerability
Sustained ChE inhibition is a significant contributor

to the efficacy of the ChE inhibitors.■ Rivastigmine appears

to have the advantage based on its ability to inhibit both

AChE and BuChE.

Research suggests that ChE inhibition by

donepezil and galantamine decreases as BuChE becomes more
active.

In a one year study, rivastigmine significantly

reduced activity of both ChE's.

However,

in a study of

donepezil and galantamine, AChE activity actually increased

after .6 to 12 months

(Grossberg,

2003).

Long-term efficacy tests of donepezil both report

positive and negative results. . These results may be due in
part to sample size.

In a study by Barak et al.

(2001), of

ten AD patients being treated with donepezil for 24 weeks, a
significant reduction in the behavioral and psychological

signs of dementia was found. These signs of dementia include

delusions, irritability,

and disinhibition.-

Also,

patients in the study tolerated the medication
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all ■

(Barak et

al.,

Research using donepezil in open-label

2001).

extension studies, using the Alzheimer's Disease Assessment
Scale cognitive subscale (ADAS-Cog), has shown that
positive effects of the drug were sustained even after 98

weeks.

However,

in another study, the same drug was

unsuccessful at revealing significant cognitive benefits

compared to placebo.

Patients reported a significant

decrease in loss of activities of daily living in addition
to improvements and cognitive and behavioral symptoms.
(Grossberg, 2003; Rocca et al., 2002).

Rocca et al.

(2002)

conducted a study to evaluate the

long-term effects of donepezil.

This study examined

outpatients suffering from mild to moderate AD.

Cognitive

impairment was measured using the ADAS-Cog as well as the
Mini Mental State Examination

(MMSE).

Activities of daily

living were evaluated using the Physical Self Maintenance

Scale

(PSMS.) .

Two patients dropped out of the study due to

adverse side effects

(severe headaches and diarrhea).

Donepezil was otherwise well tolerated in the remaining

patients.

Rocca et al.

(2002)

found that donepezil was

beneficial to patients in the study suffering from loss of
memory and other cognitive problems.

Significant

improvements were found on two scales

(.ADAS-Cog and MMSE)

until the 24th week.

After the 24-week mark,
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a gradual

decline in performance was noted.

It was also found that a

daily dose of 10 mg provided.optimum benefits from the drug.
Results of long-term studies of galantamine are also

mixed.

In a. two-part study of galantamine, totaling 52

weeks, patients taking the drug for the full 52 weeks
retained cognitive function compared to, patients who began
galantamine treatment mid-study.

At the end of the study,

no significant difference was found between the groups.

However, in a review of ChE inhibitors-,

Grossberg

(2003)

states that recent data suggests that the efficacy of
galantamine may be sustained for up to three years.

In a study of patients taking rivastigmine it was found
that patients taking the drug showed a greater clinical

improvement compared to those left untreated.

Clinical

improvement was evaluated using ADAS-Cog scores' as well as

the MMSE after taking the drug for 1-2 years.

Rivastigmine

also had a positive effect on mood, activity, decreased
l

hallucinations and paranoid behaviors
Barnes et al.

(Grossberg, 2003).

(2000) conducted a study to evaluate the

chronic effects of galantamine and donepezil in aged rats

compared to saline controls.

Barnes et.al.

(2000)

examined

differences in spatial cognition, hippocampal plas-ticity,

and nicotinic receptor binding.

It was found that both

drugs increased nicotinic binding in the hippocampus and
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prefrontal cortex, with donepezil having the greatest
effect.

Also, long-term potentiation

extended for both groups.

(LTP) decay was

A significant correlation between

nicotinic receptor number in the hippocampus and maintenance
of LTP was fotirid.

However, no significant effect was found

using a spatial working memory task (radial arm maze)

either drug group.

in

What this research suggests is that

drugs that increase the number of nicotinic receptors and
have a lower incidence of peripheral side effects, may hold
the greatest benefit to patients suffering from AD (Barnes

et al., 2000).
Tolerability and satisfaction are also important

factors to be considered when using ChE inhibitors.

In a

study of tolerability between donepezil and rivastigmine in

AD patients, it was found that donepezil was better
tolerated than rivastigmine. Caregivers and physicians also
preferred donepezil as compared to rivastigmine.

This was

based on the dosing of rivastigmine which requires titration

and twice daily dosing.

In this study,

fewer rivastigimine

treated patients were able to reach or continue the maximum

approved dosage levels

(Hock et al.,

2001).

In comparison,

a study of between galantamine and donepezil found that
patients reported less gastrointestinal adverse effects
using donepezil.

They also reported more satisfaction &
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ease of administration with donepezil

(Aarsland et al.,

2002).
AD accounts for 50-60% of dementia cases in individuals

Prevalence of AD is positively

over 65 years of age.

correlated with age

(Rocca et al., 2002).

Due to these

statistics, AD research must examine medications that will
treat various stages of AD.

This is where the efficacy and

tolerability of the ChE inhibitors must be evaluated in

groups suffering from mild to moderate AD as well as

moderate to severe AD.
Behavioral and Cognitive Effects

Wolfson et al.

(2002) conducted a review of published

randomized controlled trials as well as phase IV open label

studies.

They compared donepezil and rivastigmine' and found

that both drugs could delay cognitive impairment and

deterioration for at least 6 months in patients with mild to
moderate AD. However, after 6 months of treatment,
the ADAS-Cog were found to meet that of controls

scores on

(Wolfson

et al., 2002).
Gauthier et al.

(2000)

evaluated the effects of

donepezil on'behavior in patients suffering from moderate to
severe AD.

Significant improvements in cognition, global

functioning, and activities of daily living were found while
using donepezil.

Improvement was calculated using such
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measures as the Clinician's Interview-Based Impression of
Change with caregiver input

(CIBIC-plus), Neuropsychiatric

Inventory (NPI), Caregiver Stress scale
the Disability Assessment in Dementia

(CSS), the MMSE, and

(DAD).

A significant

reduction of stress to caregivers was also found in this

study.

Another study with donepezil was conducted by Hampel et
al.

(2002).

This study consisted of patients enrolled in a

German post marketing surveillance study.

It was found that

donepezil showed the same improvements in cognitive and
quality of life in very elderly AD patients as younger
patients. Cognition was evaluated using the MMSE and quality

of life was examined on a 3-point scale -improved,
unchanged, worsened (Hampel et al., 2002 ).

Neuroprotective Effects
Dementia is not only associated with Alzheimer's
disease but also with cerebrovascular disease.

Based on the

therapeutic effects of AChE inhibitors with patients
suffering from AD, it has been hypothesized that these drugs

may also help patients suffering from vascular dementia.

This hypothesis is not unreasonable due to the fact that
many risk factors for AD have a vascular element.
instance,

For

30% of postmortem AD brains have evidence of

cerebrovascular pathology.

Thus, the hypothesis is that
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drugs that reduce neuronal damage caused by ischemic events
may be useful in treating AD as well as vascular dementia.

Other supporting evidence is that ACh is known to enhance
the effect of nerve growth factor (NGF).

Thus the

neuroprotective role of ACh inhibitors is a valid angle for

AD research (Akasofu et al., 2003).
Akasofu et al.

(2003) examined the neuroprotective

effects of AChE inhibitors using rat cerebral cortex primary

cultured neurons.

Damage was produced by oxygen-glucose

deprivation on .cortical cell cultures from Wistar fetal
rats. Lactate dehhydrogenase

neuronal cell damage.

(LDH) was used as a marker of

Akasofu et al.

(2003). found that

donepezil possessed neuroprotective effects against in vitro
neuronal cell injury.

Donepezil significantly reduced LDH

release at even its lowest dose.

In contrast, galantamine

and rivastigmine were not successful at reducing LDH even at

their highest dose.
Other research into pharmacological treatment of AD has
focused on the involvement of additional systems such GABA.

Sarter et al.

(1996), has used benzodiazepine receptor

ligands to affect GABAergic transmission thereby influencing

presynaptic cholinergic activity.

The greatest success has

come from benzodiazepine receptor selective inverse agonists
that enhance activated ACh efflux and thus improve cognitive
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functioning.

The future of cognitive enhancers depends on

the combined the efforts of a multidisciplinary

pharmacological approach.

Consequently, there are many

different factors that may mediate the ability of ChE

inhibitors to enhance cognitive function.

It is also very

clear that more research needs to be done in order to fully

understand the mechanism of action of the ChE inhibitors.
Research also is needed to discover new drugs with less
adverse effects that are also able to reliably ameliorate

the problems associated with AD.

Research suggests that ACh

may not be the only neurotransmitter involved in the

progression of this disease, thus research should further
examine this possibility.

Perhaps in the future

pharmacologists will develop better ChE inhibitors or drugs
that interact with GABA.

Perhaps the neuroprotective

effects of the ChE inhibitors will provide more answers.

In

the meantime, careful evaluation should be given to each of
the cognitive enhancers prior to administration.

The

patient's history as well as the progression of the disease

must also be considered because they appear to play an
important role in obtaining positive results with these

drugs.
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CHAPTER FOUR
ANIMAL MODELS OF ALZHEIMER'S DISEASE

Introduction

The development of treatment for Alzheimer's disease
(AD) has been largely dependent on the use of animal models.
From the beginning,

controversial.

animal models of AD have been

Most animal models for AD include modeling

or recreating the pathological markers which are observed in
human AD brains,.

One of the main critiques of this animal

model is that these research animals used never actually
have AD itself, whereas in other animal models, the animal

may actually contract and fully develop the disease in

question (e.g., autoimmune deficiency.syndrome or AIDS).

However, the use of animal models of AD has led to many
important discoveries.

These discoveries include age-

related memory impairments in nonhuman primates, a link
between memory impairment in normal ageing as well as in AD,
and brain injury-induced impairments in attention which are
also linked with cognitive deficits

(Bartus,

2000).

A current animal model of AD involves the selective
destruction of neurons in the nucleus basalis

located in the basal forebrain using

magnocellularis

(NBM)

an immunotoxin,

192 IgG-saporin to target the cholinergic,
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or acetylcholine-containing, cells of the NBM (Wenk,

Winkler et al.,

The NBM in rats is analogous to the

1998).

human nucleus basalis of Meynert

(Fibiger,

severely degenerated in AD (Au'ld et al.,
1996; Chiba et al.,

1995; Crawley,

Lowes-Hummel, et al.,
2000; Samuel et al.,

Whitehouse et al.,

1997;

1989; Muir,

1982), which is

2002; Braak et al.,

1996; Jellinger, - 1998;
1997; Nitsch,

1994; Sarter & Bruno,

1981; Winkler et al.,

1996; Perl,

1999; Wenk,

1998).

1997;

Previous

research suggests that damage to this brain area results in

impairments similar to those observed in Alzheimer's

patients

(Muir,

1997).

Baxter and Chiba

(1999)

found that

the severity of cognitive impairment was highly correlated
with the amount of deterioration of the neurons of the basal
forebrain in rats with selective damage to those cells.
Wiley et al.

(1995) developed a method of selectively

damaging the NBM without causing damage to surrounding noncholinergic cells and fibers.

form of an immunotoxin,

This development came in the

192 IgG-saporin (SAP), which has the

ability to locate and attach itself, to receptors found only
on cholinergic neurons.

This is accomplished by virtue of

the affinity of SAP for p75''low-affinity neurotrophin

receptors, which are densely concentrated on the cholinergic
neurons in the NBM in rats.
the receptor,

Once SAP has attached itself to

it enters the cell and disrupts intracellular
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protein synthesis which ultimately results in cell death.
The result of selectively targeting the cortically-

projecting cholinergic neurons of the NBM is a profound loss
of ACh in the neocortex similar to that seen in Alzheimer's

disease

(Flicker et al.,

1985; Wrenn et al.,

1998).

The

discovery of SAP thus allowed researchers to create a better
animal model of AD in order to study the pathogenesis of AD

as well as possible therapeutic approaches.
The development of the selective cholinergic neurotoxin

SAP has contributed greatly to the understanding of the role
of ACh in learning, memory and cognition.• Many forms of

attention,

such as divided and sustained attention, have

been found to be sensitive to selective cholinergic lesions.
However, there are still aspects of the cholinergic system

function that remain a mystery.

Although many studies have

used SAP to damage the cholinergic neurons of the NBM, the

results from these studies have been varied.

However, this

variability may be due to the different means of

operationalizing the psychological construct in question as
well as the task used to measure it, rather than to

differential effective use of SAP itself.

Steckler and Muir (1996)

According to

there are many promising behavioral

paradigms that attempt to compare cognitive functioning in
rodents to humans. However, developing a valid task for
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■

assessing-cognitive functioning can be quite difficult.
There are many variables to be considered when attempting to

develop a behavioral paradigm that will provide meaningful

comparisons between rats and humans.

Such variables include

procedural variables, task complexity, and the dynamics of
the cognitive processes themselves

(Steckler et al.,

1996).

It is extremely important that the behavioral paradigms

used in animal models of AD are- appropriate for the
cognitive processes in question.

For example, there are

various types and degrees of attention and subtle

■ ■

differences in attention may result in very different

impairments.

This is highly relevant since cortical ACh and

the cholinergic neurons of the nbM have been found to be
related to attention in humans

(Perry & Hodges et al.,

Sarter & Bruno,

1994; Sarter & Bruno,

Givens, 2003).

As a result of the

1999;

1999; Sarter, Bruno,

&

success of research

using the immunotoxin SAP in targeting cholinergic neurons,
SAP has been the toxin of choice for many lesion studies

related to AD and attention.
As recognized by Steckler et al.

(1996), when assessing

attention, the behavioral task must address the specific

elements of the type of attention studied.

For instance,

sustained attention tasks must require that the subject
respond to unpredictable changes in stimulus conditions.
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For these types of tasks the number of stimuli, rate of

stimulus presentation, and event rate are -crucial to the .
effect of.the task.

The 2-choice reaction time task

developed by Pang (1992), an operant 2-choice task developed

by McGaughy and Sarter (1995), and the 5-choice serial
reaction time task developed by Robbins
sustained attention.

(2002), all measure

For selective attention, the 5-choice

serial reaction time task and measures of latent inhibition
are most commonly employed.

A disadvantage with these tasks

is the problem of separating changes in selective attention
with those of associative learning.

For assessing•divided

attention, the simultaneous presentation of two stimuli is
used, partly because with successive presentation of stimuli

it is difficult to determine whether the effects are due to

impaired parallel processing or to impaired attention

(Steckler et al.,

Wenk (1997)

1996).

reviewed the impact that damaging the NBM

cholinergic neurons has on cognition.

Electrophysiological

studies of SAP lesioned animals suggests that the

corticopetal NBM cholinergic system is involved in the
control of shifting attention to relevant stimuli.

Additionally,

selective damage to the cholinergic neurons of

the NBM may impair the ability to focus on and process

briefly presented relevant sensory stimuli.
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These

impairments are consistent with those associated with damage

to the nbM in humans with AD (Sarter,
1999; Sarter, Bruno,

& Turchi,

1994; Sarter & Bruno,

1999).

In addition to studies showing NBM involvement in

attention, other AD animal models have linked cholinergic

neuron damage caused by SAP to impairments in learning and
memory (Gallagher,
al.,

1995).

& Colombo, 1995; Wenk,

1997; Wiley et

in order to test the effects of

First,

intraventricular injections of SAP, where this lesion method

damages the NBM as well as the medial septal cholinergic
projections to hippocampus, Wiley et al.

(1995)

compared

animals lesioned by intraventricular injections of 0X7-

Saporin to controls.

The behavioral effects of this lesion

technique were evaluated using step-down and step-through

passive avoidance tasks, as well as using an assessment of
open field activity.

Wiley et al.

(1995). found that SAP

lesion rats were impaired in learning to avoid shock in the

passive avoidance tasks.

This study suggests that

cholinergic neurons in the basal forebrain are important for
memory formation.

Results also support that damage to the

cholinergic neurons of the basal forebrain result in memory
impairments similar to those found in AD patients

al.,

1995) .

47

(Wiley et

Perseverative Impairments After Nucleus Basalis
Magnocellularis Lesions
For instance, Wilson and Cook (1995)

found'that rats

with electrolytic NBM lesions made more perseverative errors

than controls during the acquisition and reversal of a

visual discrimination task. However, this study involved the
electrolytic lesion technique which damages brain tissue by

producing heat.

This technique therefore damages not only

the cholinergic cells of the NBM but also nearby non-

cholinergic cells and fibers.

Because of this additional

damage, perseveration observed in this cannot be

unambiguously linked to cholinergic NBM cell loss, as it is
possible that these lesion effects were caused by extraneous

brain damage.

Attention Impairments After Nucleus Basalis
Magnocellularis Lesions
The construct of attention can be divided into

different sub-types of attention: vigilance or sustained
attention, and divided attention.

Vigilance or sustained

attention is the ability to resist distractions and continue

a task set without interruptions. Divided attention is
reflected in the ability to do more than one task at a time.

(Muir,

1996; Perry & Hodges,

1999).

Vigilance has been described as the ability and ease
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with which one can detect and respond to random and

(Sarter et al., 2001). Thus, common

infrequent stimuli

vigilance tasks usually involve discriminating between

signals and non-signals

1996; Sarter et al., 2001).

(Muir,

Vigilance involves many other processes and cognitive
states, such as arousal and alertness

(Perry &' Hodges,

1999).

Many studies have strongly supported cholinergic

involvement with vigilance.

For example, lesions of the

basal forebrain have led to impairments in sustained
attention tasks.

The degree of impairment has also been

found to be associated with the level of damage to cortical
cholinergic inputs.

In addition, changes in activity of the

cortical cholinergic inputs have lead to changes in
sustained attention performance.

Activation of the basal

forebrain increases activity of cholinergic inputs to the

cortex and in doing so improves sensory processing as well
sustained attention performance. Additionally,

release of

ACh in the cortex of animals during a sustained attention
task is linked to the level of cognitive demand (Sarter et

al., 2001).

McGaughy et al.

(1996)examined performance of rats with

SAP lesions of the NBM in a behavioral vigilance designed to

measure sustained attention.

The task included visual
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signals of various, lengths and required rats to discriminate
signal from non-signal events.

Results of this study .

revealed strong and persistent impairment's in sustained
Rats with SAP lesions of the NBM were impaired

attention.

at detecting signals but were still .able to correctiy reject
non-signals.

In lesioned rats, cortical AChE-positive fiber

density was reduced by 29-86%, except for in the basolateral

amygdala.

In most areas, performance was found to be

significantly correlated with cortical AChE-positive fiber
density, where lesser density correlated with poorer

attention performance.

In another sustained attention study, McGaughy and
Sarter (1998) used smaller concentrations' of SAP to. produce

partial lesions of the cortical cholinergic inputs from the
basal forebrain.

Next, they evaluated the.

effects of the

cholinesterase inhibitor physostigmine and benzodiazepine

receptor partial inverse agonist FG 7142.

Sustained

attention was measured in an operant task previously used by
McGaughy et al.

(1996) that required rats to discriminate1

signal from non-signal events.

In addition to impairments in. sustained attention, rats
with SAP lesions of the nBM show impairments in divided

attention.

Waite and colleagues

(1999)

compared the

behavior effects of SAP on rats using a multiple choice
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reaction time task, water maze, passive avoidance, acoustic
startle and open field activity.

Rats with cholinergic

basal forebrain lesions had difficulty focusing attention,
adjusting to changes in timing of trial presentation,

coping with increases in attentional demand.

and in

These data

suggest that damage to the basal forebrain impairs divided

attention and also causes a more general disruption of
cognitive flexibility.
Divided attention has also been linked to cortical

cholinergic input.

Turchi and Sarter (1997)

compared the

effects of SAP lesions of the corticopetal cholinergic

neurons of the NBM to sham-operated controls using an

operant cross-modal divided attention task.

The task used

two-choice conditional visual and auditory discriminations.
Rats were presented with two conditions of

modality-certainty and modality uncertainty.

In the

certainty condition, rats were presented with only a visual

or an auditory discrimination.'

In the uncertainty modality,

rats were presented with a randomized sequence of all

stimuli of both modalities. ■ A session consisted of 2
unimodal blocks of trials

(20 trials each)

bimodal block of 60 trials.

followed by a

The NBM lesion group was able

to perform each discrimination as well as controls in the

unimodal condition, but showed significant impairments in
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the bimodal conditions

(Turchi & Sarter,

1997).

Results of

this study suggest that ACh mediates the control and
distribution of resources used for cognitive processing.•

Results also reveal a lesion induced decrease in processing
capacity as well as a preseveration of response accuracy at

The authors hypothesize

the expense of response latency.

that lesions of the NBM compromise processing capacity by

making it difficult for rats to process different sets of

response rules

(see also, Muir,

1996).

Impairments in

divided attention have also been found to be associated with
aging and neuropathology such as Alzheimer's disease.

Previous research suggests that impairments in divided
attention are related to deficits in processing capacity
(Muir,

1996)

Research with human AD patients have similarly found
impairments in divided attention.

This is particularly

important because impairments in divided attention have been
found to be associated with early AD.

For example,

in a

dual task experiment, no significant differences were found

between AD patients and controls when asked to perform the
two tasks separately.

However, when asked to perform the

two tasks at the same time, AD patients were impaired
(Baddeley, Bressi,

Perry & Hodges,

Della Saia, Logie,

& Spinnler,

1991;

1999; Grady, Grimes, Patronas, Sunderland,
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Foster,

& Rapoport,

1989; Spinnler, 1991).

Grady et al.

(1989) also found impairments in divided attention among AD
patient’s.

AD patients were, subjected to the Staggered

Spondaic Word Test, which is a dichotic listening test.

In

this experiment, AD patients were first tested on a test of

auditory presentations in one ear at a time.

Results were

then compared to the same patient's performance in the

dichotic listening task where participants were expected to
divide their attention between two different auditory
stimuli presented to each ear at the same time.

A greater

impairment was found in AD patients during the dichotic

listening task than when tested one ear at a time.

This

type of impairment has generally been interpreted as being
an impairment in divided attention.

However,

it has also

been hypothesized to be an impairment of the central

executive system (Perry & Hodges,

1999).

Impairments in Cognitive Flexibility After Nucleus
Basalis Magnocellularis Lesions

The impairments in divided attention and the

observation of perseveration typically observed following
NBM damage might both, reflect a common underlying impairment
in cognitive flexibility.

Cognitive flexibility has been

defined, as the ability to shift cognitive set,
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or to shift

attention in order to' perceive, process, or respond to
situations in different ways

Rende, 2000).

(Eslinger & Grattan,' 1993';

Indeed, AD patients show impaired-verbal

fluency production (Monch et al.,. 1992),

impaired

performance on the Wisconsin Card Sort Task (Paolo, Axelrod,

Troster, Blackwell,

1996), perseveration

& Koller,

impairments .(Bayles et al.', 2004; Ryan et al.1995; Lamar, et
al.,

1997; Caccappolo-van Vliet et al.,

2003),

and

difficulties with changing behavior in response to changes
in reinforcement contingencies

(Bigler et al.,

1988).

Each

of these tasks has been linked to the concept of cognitive

flexibility (Rende, 2000), suggesting.that disruptions in
this more global cognitive function might account for this
wide variety behavior impairments.

Animals with NBM damage show impairment in several

behavioral tasks related to the, construct of cognitive
flexibility.
(e.g.

These tasks include measures of perseveration

serial reversal tasks),-divided attention, configural

association learning, learning set formation and set
shifting.

Again,

a common impairment in cognitive

flexibility could account for- these varied behavioral

impairments following NBM lesions.
Ridley et al.

(1985)

found significant post-operative

perseveration in marmosets with ibotenic acid-induced

54

lesions of the NBM.

Ibotenic acid produces -excitotoxic

brain injury damaging cholinergic but also non-cholinergic
cells.

These animals were tested in a serial reversal task,

where■animals first learn to discriminate between a
reinforced and non-reinforced cue.

Subsequently, the

reinforcement contingencies were reversed such that

continuing to respond to the previously correct cue
perseverating)

disrupted performance.

(i.e.,

This finding of

impaired performance in these marmosets suggests a role for

the NBM in mediating perseveration.

However, this argument

is weakened by the fact that ibotenic acid lesions, like

electrolytic lesions, produce non-selective damage in
addition to NBM cell loss.

More recently, Ridley and colleagues
1997)

(Fine et al.,

examined learning impairments, in monkeys, following

administration of the more selective cholinergic immunotoxin

SAP.

Prior to surgery, monkeys were trained on a series of

visual discrimination problems. During surgery, monkeys were
injected either with saline or increasing amounts of SAP

into the NBM and then presented with a serial reversal of a

visual discrimination problem.

Fine et al.

(1997)

tested the

effects of scopolamine on acquisition and reversal of the
same task.

Results indicate a relationship between damage

to the NBM, amount of cortical AChE, and task performance.
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Lesioned animals treated with scopolamine showed significant
impairment on acquisition and reversal as compared to
controls.

However, impairments were only revealed in

animals with significantly large NBM lesions
doses of SAP)

and AChE loss.

(due to large

These results suggest that.

cholinergic neurotransmission contributes to serial reversal
learning.

Previous research has also shown that NBM lesions in

rats impair the ability to divide attention.
Bowman (2002)

Butt and

studied configural association'learning versus

simple association learning in rats with SAP lesions of the

NBM.

NBM lesion rats were able to discriminate between

simultaneously presented black and white visual cues, and

later were able to discriminate between white and striped

visual cues.

However, performance in these same animals was

impaired when the two visual discrimination problems were
presented randomly within the same session.

These results

suggest an impairment in the ability to switch between

strategies for solving different problems.

Such an

impairment might reflect compromised cognitive flexibility
in general.

Butt and colleagues

(Butt, Noble, Rogers,

& Rea, 2002)

found impairments in cognitive flexibility in NBM SAP
lesioned rats in a negative patterning task.
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NBM SAP

lesioned rats and sham-operated controls were tested in a

simple discrimination task that tests simple association

learning, and were also tested in a negative patterning
paradigm that tests configural association learning.

In the

negative patterning task, the separate presentation of a

tone or light was reinforced.

However,

simultaneous

presentation of the light and tone was not reinforced.

NBM

lesioned.rats were impaired during acquisition of the
negative patterning task, although performance in the simple

association task was spared.

The authors suggest that the

observed configural association learning impairment may have
been due to a loss in ability to attend to multiple sensory
stimuli or to adjust to changes in response requirements
that vary as a function of stimulus configuration.

In another study, Butt et al.

(2003)

compared

performance of rats with bilateral SAP lesions of the NBM
with control animals in an operant appetitive-to-aversive

transfer task.

In the initial appetitive phase,' rats.were

trained to press a bar in response to tone presentation in
order to receive food reinforcement
learning).

(simple associative

In the subsequent aversive phase, tone

presentation signaled impending shock.

Upon transfer from

the appetitive to the aversive phase in the task,

animals

must attend to the change in the predictive significance of
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the tone in order to learn to bar press to avoid shock.'
Following the shift from appetitive-to-aversive conditions,
sham operated controls revealed a large positive transfer

effect; acquisition in the aversive phase was more rapid in
the transfer group than in a control group tested only on

the aversive task.

In contrast, the NBM lesioned rats

showed acquisition impairment in the aversive phase of the
appetitive-to-aversive transfer task. ' This impairment was

specific to the transfer condition, as rats with NBM lesions
tested only on the aversive task showed .normal acquisition.

This experiment suggests that NBM lesions disrupt the
ability to switch between appetitive and avoidance

strategies upon transfer between the two phases of the task.
It also suggests that the NBM is important for strategy

switching behaviors in particular, cognitive' flexibility in
general.
Previous research using SAP lesions of the NBM have

found impairments in learning set formation

(Bailey et al.,

2003), another index of cognitive flexibility (Rende,

Bailey et al.

2000).

(2003) tested'rats with SAP lesions of the NBM

on an olfactory discrimination learning set task (ODLS),

followed by an olfactory discrimination reversal learning
set

(DRLS).

Lesions of the NBM impaired•initial acquisition

of the learning set in the ODLS task, although both NBM rats
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and controls showed evidence of learning transfer from the
ODLS to the DRLS task.

Collectively, these findings suggest that NBM lesions
cause disruptions in learning, attention, and cognition.
These varied findings can potentially be related to the
unifying construct of impaired cognitive flexibility.

As

research on impaired cognitive flexibility in human AD
continues, and as more researchers test for impairments in

animal tasks assessing cognitive flexibility following NBM
damage, this argument may be further substantiated.

59

CHAPTER FIVE

THESIS EXPERIMENT

Introduction
Alzheimer's disease (AD)

causes severe cognitive

impairments and is partly characterized by cholinergic cell
loss in the nucleus basalis of Meynert in humans

al.,

2002; Braak et al,

1996; Jellinger,
1997; Nitsch,

et al.,

1995; Crawley,

1998; Lowes-Hummel, P. etal.,

1996; Perl, 2000; Samuel et al.,

1999; Wenk,

& Bruno,

1996; Chiba et al.

(Auld et

1997; Whitehouse et al.,

1989; Muir,
1994; Sarter

1981; Winkler

This form of dementia affects more than 5

1998).

million people in the United States today.

A current animal

model of AD involves the use of the immunotoxin 192 IgG-

saporin (SAP)

to destroy the cholinergic neurons in the

nucleus basalis magnocellularis

(NBM), the rat brain

structure analogous to the human nucleus basalis of Meynert
(Fibiger,

1982) .

Previous research’ using SAP to damage the NBM suggests

that this brain structure may be involved in supporting

cognitive flexibility.

Impairments in divided attention,

configural association learning, learning set formation, and

strategy switching have all been found following selective
SAP lesions of the NBM (Bailey et al.,
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2003; Butt & Bowman,

2002; Butt et al., 2002; Butt et al., 2003; Turchi & Sarter,

1997).

Additionally, previous research using non-selective

lesion techniques have similarly shown that NBM damage

impairs the ability to form learning sets.

Bailey et al.

For example,

(2001) used quisqualic acid to damage the NBM

(but also causing damage to non-cholinergic neurons)

rats.

in

These animals were tested on a learning set task

where a common discrimination rule was to be applied across
a series of novel exemplars. According to Bailey et al.

(2001), the NBM is important in "learning to learn", where
this type of learning requires higher level cognition.

However, due to the non-selective nature of the lesion
method used, the resulting cognitive impairments cannot be

unequivocally linked to NBM damage alone.

by Bailey et al.

A follow-up study

(2003) again found learning set formation

impairments in rats with SAP lesions at the NBM, although
these impairments were transient.

Consequently, the extent

to which the NBM critically contributes to cognitive

flexibility remains to be determined.

Bigler et al.

(1988) note that AD patients have

difficulty changing behavior in the face of changing
reinforcement contingencies.

Such behavioral impairment can

lead to response perseveration, a specific form of cognitive

inflexibility or ridigity.

Indeed, perseveration is defined
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as inappropriate persistent responding such that the person
or animal repeats or fails to inhibit a previous response

(Bayles et al., 2004; Galdi,

1993).

Additionally,

evidence

suggesting that perseveration can result from disrupting
cholinergic function has been reported in normal humans
treated with anticholinergic drugs

(Bigler et al.,

1988).

Animal research further supports the argument that the

NBM might be involved in inhibiting perseverative behavior.

In a previous study, for example, rats with electrolytic NBM
lesions were tested on the acquisition and reversal of a
visual discrimination task.

In this task,

animals first

learned to discriminate between a reinforced and a non-

reinforced cue, before the reinforcement contingencies were
reversed such that continuing to respond to the previously

correct cue

(i.e.., perseverating) would interfere with

performance under the new reinforcement contingency.

The

NBM lesion group made more perseverative errors than
controls during the reversal of this experiment,

suggesting

that the NBM is normally involved in inhibiting
perseveration under changing reinforcement contingencies

(Wilson & Cook,

1995).

However, the electrolytic lesion

technique damages not only the cholinergic cells of the NBM

but also nearby non-cholinergic cells and fibers.

Because

of this additional damage, perseveration observed in this
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study cannot be unambiguously linked to cholinergic NBM cell
loss, as it is possible that the effects were caused by

extraneous brain damage in addition to or instead of being
caused by NBM damage per se.

Ridley et al.

(1985) found significant post-operative

perseveration in marmosets with ibotenic acid-induced
lesions of the NBM.

Although these findings again suggest a

role for the NBM 'in mediating perseveration, this argument

is weakened by the fact that ibotenic acid lesions,

like

electrolytic and quisqualic acid lesions, produce non-

selective damage to cells or fibers in the vicinity of the
NBM.

Cholinergic involvement in perseveration is also
suggested by pharmacological data from research using the

muscarinic receptor antagonist scopolamine

(Mason,

1983).

Rats that received injections of scopolamine during

extinction of an operant task showed greater resistance to
extinction compared to saline-treated controls.

Response

latencies for the scopolamine-treated rats were
significantly shorter than in controls, suggesting that the
scopolamine-treated rats were perseverating on the operant

response despite non-reinforcement.
In the current experiment, the highly selective

cholinergic immunotoxin SAP was used to lesion the NBM in
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rats before testing these animals in a serial reversal task
and in a subsequent extinction test.

Data from both the

serial reversal task and the extinction test provided a
measure of response perseveration and, therefore, cognitive

It was hypothesized that the NBM lesion group

flexibility.

would acquire the initial operant discrimination between a

food-reinforced tone (T+) and a non-reinforced light
well as controls.

(L-) as

This hypothesis was based on the findings

by Butt and colleagues

(Butt & Bowman, 2002; Butt & Hodge,

1997) that the NBM is not necessary for learning such simple
associations.

In contrast, it was hypothesized that subsequent serial

reversal performance would be impaired in the NBM lesion
group compared to controls.

Specifically, across serial

reversals, it was predicted that the NBM lesion group would

make more errors across days and would require more days of
training to reach an a priori performance criterion than

controls.
Additionally, it was hypothesized that there would be
an interaction effect between type of lesion and consecutive

reversals on both errors to criterion and days to criterion.
While the control group

(including the sham-lesion and the

non-operated rats) was expected to show progressive
improvement

(i.e.,

fewer errors and fewer days required to
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reach criterion)

across successive reversals, the NBM lesion

group .was not expected to show such improvement. Because SAP

selectively targets the cholinergic cells of the NBM while
sparing adjacent brain tissue (see Wiley et al.,

1991), any

behavioral impairments observed following SAP lesions of the
NBM can unambiguously be'attributed to the loss of

cholinergic NBM cells.

This poses an advantage over

previous research assessing cognitive flexibility in rats

with non-selective NBM lesions tested in serial reversal

paradigms.
Immediately following completion of four reversals,
rats proceeded to an extinction phase. Based on the argument
that NBM lesions cause perseveration,

it was expected that

the NBM lesion group would extinguish the serial reversal

task more slowly than controls.

That is, when the

contingency changed from reinforcement to non-reinforcement
during extinction training, the NBM lesion group was

expected to continue to respond due to difficulties altering

behavior in response to changes in reinforcement
contingencies.

Additionally, it was predicted that there

would be an interaction effect between type of lesion and
day of extinction testing on total number of responses.

While the control group (including the sham-lesion and the
non-operated rats) was expected to extinguish operant
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responding (i.e., to show a progressive decrease in total
number of responses)

rapidly across extinction test days,

the NBM lesion group was not expected to extinguish as

quickly.

Methods
Design

The study consisted of three experimental phases:
acquisition,

serial reversal, and extinction.

Acquisition

consisted of operant discrimination between a foodreinforced tone

(T+) and a non-reinforced light

(L-).

This

original acquisition was followed by a reversal phase

consisting of four serial reversals of the original operant
discrimination.

Finally, the extinction’phase consisted of

extinction trials, where neither the light nor tone signal

was reinforced.

Acquisition.

In the first phase of the study

(acquisition), a between-subjects two-group design was

adopted.

The independent variable

(type of lesion)

consisted of two levels: the NBM lesion and the control

(including sham-lesion and non-operated rats).

During this

phase there were two dependent measures: total number of

errors committed prior to reaching criterion and total
number of days required to reach criterion.
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Serial Reversal.

The second phase

(serial reversals)

consisted of four reversals following acquisition.

phase, a 2 x 4 mixed design was adopted.

In this

The first

independent variable (type of lesion) was a between-subjects

variable

(the same as the one manipulated in the acquisition

phase).

The second independent variable

(reversal number)

was a within-subjects variable consisting of four levels.
Each level of this variable referred to one of the four

reversals..

During this phase, two dependent variables were

measured: errors to criterion and days to criterion.

"Errors to criterion" was defined as the total number of
errors committed prior to reaching criterion for each of the

four reversals.

"Days to criterion" was defined as the

total number of days required to reach criterion.

Extinction.

In the final phase

(extinction, which

immediately followed completion of the fourth reversals in

phase two)

a 2 x 4 mixed design was adopted.

Once again, in

this phase, the between-subjects independent variable,

namely type of lesion, was Included.

variable

The second independent

(day) was a within-subjects variable and consisted

of four levels which pertained to each of the four days of

extinction testing. During this phase, one dependent
variable

(i.e., the total number of responses emitted during'

each day of extinction testing) was measured.

67

Animals
A total of 22 male Long-Evans rats

(appx. weight 250 g

upon arrival) were purchased from a commercial research
animal vendor

(Harlan,

Indianapolis,

IN).

Rats were

individually housed under a 12 hr light/dark cycle with ad

libitum water and standard rat chow prior to surgical and

behavioral manipulations..

Prior to surgery and subsequent

behavioral testing, rats were randomly assigned to one of
three groups: NBM lesion, sham-lesion, or non-operated

control.

After surgery, rats were reduced to and maintained

at 85% of their free-feeding body weight in order to
motivate operant behavior. Rats were fed a restricted amount

of food immediately on returning to their home cages after

each shaping or testing session.

Apparatus
Testing was conducted in individual computercontrolled,

sound-attenuating operant chambers with

discriminative stimuli consisting of a tone or cue light.
Reinforcement consisted of the delivery of a sucrose pellet
(45 mg; P.

J. Noyes Co., Lancaster, NH)

into the magazine

located at floor-level along the front panel of the chamber.
Stimulus onset, lever-press response detection, and

reinforcement delivery were programmed and controlled via

computer interface.
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Surgery
Surgical procedures were identical to those used byButt and colleagues

(Butt & Bowman, 2002; Butt et al.,

Rats were anesthetized with sodium pentobarbital

2002).

(55

mg/kg)' before making bilateral craniotomies above the NBM.
Craniotomies were located at -0.75 mm posterior to bregma,
±2.3 and ±3.3 mm from midline.

11),

SAP

(n =

In the NBM lesion group

(concentration 0.4 pg/pl in saline; Chemicbn,

Temecula, CA) was infused directly into the NBM of both

hemispheres at -7.8 mm below the skull for the medial sites,
and at -8.1 mm below the skull for the lateral sites.

Once'

the cannula was lowered into the brain, there was a 2 min
waiting period to permit the brain to settle around the

cannula.

Following infusions, there was a 3 min waiting

period to allow for diffusion of SAP away from the cannula
tip.

Rats in .the sham lesion control group

(n = 7)

underwent the same surgical procedure as the NBM lesion

group except that they received intracerebral infusions of
sterile saline only.

Rats were sutured and allowed 10 days

to recover prior to testing. Rats in the non-operated
control group

(n = 4) did not undergo any surgical

procedures.

69

Behavioral Procedure
Rats were first shaped to press a lever in the operant

chamber for food reinforcement. Rats received three sessions
of lever-press shaping on a continuous reinforcement

schedule in which each session was terminated after 50

reinforcers had been delivered or after 1 hr elapsed,

whichever came first. Rats then received three additional

shaping sessions under a variable interval

(VI)

schedule of

reinforcement in which up to 50 reinforcers were delivered
at intervals ranging from 0 to 80 s, with an average

interval of 40 s

(VI-40 s). Each VI-40s session terminated

after 50 reinforcers had been delivered or after 1 hr had
elapsed, whichever came first.

Next, rats were presented with an operant
discrimination consisting of 60 reinforced tone

nonreinforced light

(L-) trials.

an average inter-trial interval

(T+)

and 60

Trials were separated by

(ITI)

of 40 s.

Training

continued until rats reached an a priori criterion, defined

as a discrimination ratio (number of correct responses /
number of correct responses + incorrect responses)

greater for two days

(consecutive or otherwise).

of 80% or
Rats then

proceeded to a reversal of the original discrimination where

the reinforcement contingencies associated with the tone and
light were reversed (i.e., T-, L+) .
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Training continued to

criteria, when contingencies again were reversed.

Rats

underwent a total of four reversals, in addition to the

initial task acquisition.

Upon completing the fourth reversal,

rats proceeded to

extinction trials where neither cue was reinforced. Rats
were presented with one extinction session per day for four

days.
Histology
Following the completion of behavioral testing,

rats

were sacrificed by lethal dose of sodium pentobarbital

(80

mg/kg, ip; Sigma, St. Louis, MO) followed by cardiac

perfusion first with 0.9% saline, then with 4.0% phosphatebuffered formalin, and finally with 5% phosphate-buffered
sucrose solution. In addition to using chilled perfusion

solutions, rats' heads were kept on ice throughout perfusion

to prevent the degradation of the enzyme
acetylcholinesterase (AChE).

Brains were then extracted and

placed first in a phosphate-buffered 10.0% sucrose solution

for 24 h and then in a phosphate-buffered 25% sucrose

solution for another 24 h prior to freezing and sectioning
(60mm)

in a cryostat.

Alternate sections were then stained

for AChE using the method of Karnovsky and Roots

(1964).

AChE-stained sections were examined to verify the placement
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and extent of the NBM lesions and to determine the extent of
cortical cholinergic denervation.'
Data Analysis

Acquisition of the initial discrimination

Acquisition.

was analyzed by two separate two-tailed t-tests for
independent samples.

One testing the number of errors

committed prior to reaching criterion and one testing the

number of days required to reach criterion.

Serial Reversal.

Serial reversal performance was

analyzed by two separate ANOVAs' for mixed designs.

in

addition, independent-samples t-test were used to test

between group differences on each reversal.

The dependent

measures were the number of errors committed prior to
reaching criterion and the number of days required to reach
criterion on each of the four discrimination reversals.

Extinction.

Extinction data were analyzed by a single

ANOVA for mixed designs. The dependent measure was the total
number of responses emitted on each of the four days of

extinction testing.
A significance level of p = .05 was adopted to conclude

statistical significance for all analyses.
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CHAPTER SIX
RESULTS

Sham-Lesion and Non-Operated Controls
Data from animals in the sham-lesion and non-operated

control groups were compared prior to combining these groups
for subsequent analyses.

No between-group differences were

observed for either the days to criterion or errors to

criterion measures during acquisition of the original
discrimination,

t(9) = -1.348, p > .05, and t(9) = -1.149, p >

.05, respectively.

During reversal training, there was no significant
between-group

(sham-lesion vs. non-operated control)

difference on the number of days to reach criterion,

F(l,

9)

= 0.024, p > .05, or on the number of errors to reach

criterion,

F(l,

9)

= 1.121, p > .05.

Although no between-

group differences were found, there was a significant main
effect for "reversal number" on days to criterion,

16.245, p <.05, as well as errors to criterion,
,

F(l,

9) =

F(1

9) = 28.937, p < .05, where both measures decreased across

successive reversals.

No interaction between "type of

lesion" and "reversal number" was observed for either days
to criterion or errors to criterion, indicating that trends

in performance across the four reversals did not differ
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between the sham-lesion and the non-operated control groups.
Because no between-group differences were found for both
days to criterion and errors to criterion, data from these

two control groups were combined. Hereafter, the combined
group

(including the sham-lesion and the non-operated rats)

will simply be referred to as the control group.

Acquisition

Acquisition of the original discrimination did not
differ across testing sessions between the NBM lesion and

control groups

(see Figure 1).

The results of two separate

independent-samples t-tests confirmed these observations.
There were no significant between-group differences in the

number of days required to reach criterion
Part A)),

t(20) - .093, p > .05.

(see Figure 2,

Additionally, there were

no significant between-group differences in number of errors
committed prior to reaching criterion (see Figure 3,

A),

t (20) = .027, p > .05.
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Part

Acquisition

Day

Figure 1. Mean (+/- SEM)

Percent Correct During the

Acquisition Phase For Nucleus Basalis Magnocellularis and
Control Groups in the Serial Reversal Task.
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Days to criterion
12

Figure 2.

Mean

(+/- SEM)

Days Required To Reach Criterion

During Acquisition (A).
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Figure 3.

Mean (+/- SEM) Errors Required To Reach-

Criterion in the Nucleus Basalis Magnocellularis and Control

Groups During Acquisition (A).
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Serial Reversal

One animal from the NBM lesion group was dropped from
the experiment because of scores that were significantly

different

(greater than 2 SDs)

from the mean of other

animals in the NBM lesion group.

This animal's superior

performance may have resulted from an incomplete lesion,
although existing

techniques in our laboratory are insufficient to quantify
potential differences in the magnitude of NBM lesions.
Serial reversal performance was impaired in the NBM

lesion group compared to the control group

(see Figure 4).

Separate ANOVAs for mixed designs on the number of errors

committed prior to reaching criterion, and on the number of

days required to reach criterion confirmed this observation
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Percent Correct for Serial Reversals

Figure 4.

Mean ( + /- SEM) Percent Correct Across the

Four Reversals For the Nucleus Basalis Magnocellularis and

Control Groups in the Serial Reversal Task.

The Nucleus

Basalis Magnocellularis Group Demonstrated Perseveration in
Reversal 1, Requiring More Days To Reach Criterion Than

Controls

(See Figure 5, Part B ).
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Degrees of Freedom

The assumption of sphericity was not met with either

the ANOVA on days to criterion or the ANOVA on errors to
criterion.

Consequently, Greenhouse-Geisser adjustments

were applied to within-group main effects and to
interactions to adjust the degrees of freedom for the

averaged tests of significance on both of these measures.
Days to Criterion
A significant between-group difference was found for

the number of days to reach criterion

(see Figure 4),

F(l,

20) = 6.318, p < .05. The results of additional independentsamples t-tests revealed that the main effect for type of

lesion on days to criterion was due to the group difference
occurring on the first reversal,

t(20) = 2.864, p < .05.

No

significant between-group differences were•observed on each
of the subsequent reversals.

A significant main effect for "reversal number" on
number of days to reach criterion was also found,

F(2.154,

43.084) = 33.682, p < .05, demonstrating a decrease in the
number of days to criterion across successive reversals in

both groups.

A significant "reversal number" by "type of

lesion" interaction yielded an F(2.154, 43.084)

= 4.806, p <

.05, indicating that performance in the NBM lesion group and

the control group did not change at the same rate across the
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four subsequent reversals. This interaction reflects a large

between-group difference in days to criterion observed on

the first reversal followed by recovery in the NBM lesion

group (indicated by the small between-group difference in
days to criterion)

on each of the subsequent reversals

(see

Figure 4).

Days to criterion

A

R1

R2

R3

R4

B

Figure 5. Mean (+/- SEM)Days Required To Reach Criterion
in the Nucleus Basalis Magnocellularis and Control Groups

Across Four Reversals

(Rl Through R4)

Task (B).
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in the Serial Reversal

Errors to Criterion
No significant between-group difference was found for

number of errors to reach criterion (see Figure 6),

= 3.107,. p > .05.

F(l, 20)

A significant main effect for reversal

number on the number of errors to reach criterion was found,

demonstrating a decrease in the number of errors to reach
criterion across successive reversals in both groups,

F(2.108, 42.156)

= 24.871, p < .05.

The reversal number by

type of lesion interaction for errors to reach criterion was
also significant,

F(2.108,

42.156) = 3.086, p = .05.

A

large between-group difference in errors to criterion was
observed on the first reversal followed by recovery in the

NBM lesion group

(indicated by the small between-group

difference on errors to criterion)
reversals

(see Figure 6).
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on each of the subsequent
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Figure 6.

Mean

(+/- SEMj Errors Required To Reach

Criterion in the Nucleus Basalis Magnocellularis and

Control Groups Across Four Reversals

the Serial Reversal Task (B).
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(R1 through R4)

in

Extinction

One animal was removed from the analysis of extinction
data because it was inadvertently run on a fifth reversal,
which may have affected performance during subsequent

extinction.

No significant between-group difference was

found for total number of responses during extinction,
11) = 2.107, p > .05.

F(l,

A significant main effect for

extinction day was found on the total number of responses,
F(3, 33) = 9.204, p < .05, where total number of responses

decreased across successive days.

There was no extinction

day by type of lesion interaction for total number of
responses,

F(3, 33) = 1.833, p > .05,

indicating that

patterns in performance did not differ between the NBM

lesion and control groups

(see Figure 7).

Examination of the extinction patterns in Figure 7 suggests
that performance in the NBM lesion and control groups did in

fact differ, but only after the first day of extinction
training. On Day 1, both groups responded equally, which

suggested no differences in resistance to extinction.
Consequently, each day of extinction was analyzed separately

using independent-samples t-tests.
Independent-samples t-tests for each of the four days
of extinction revealed that the significant between-group

difference on total number of responses occurred only on the
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second day of extinction,

t(12)= 2.817, p <.05, with the NBM

lesion group making more total responses than the control

group.

0 j-----------------------------------------------3

12

4

Extinction Day

Figure 7.

Total Responses During Four Days of Extinction

of the Previously Reinforced Cues of the Serial Reversal
Task.

The Nucleus Basalis Magnocellularis Group Made More

Perseverative Responses During Extinction Than Controls

Across Days 2-4 Of Testing, Although Initial Extinction

Performance Did Not Differ Between Groups.
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Histology

Differences in AChE-positive staining were observed
between the cortices of rats in the NBM lesion and sham-

lesion control groups

(see Figure 6).

In addition to the

depletion of AChE throughout the cortex, brains from the NBM

lesion group showed a loss of AChE-positive fibers and cell
bodies in the vicinity of the NBM, whereas no such loss was

found in sham-lesion control brains.

Additionally, SAP

lesions of the NBM did not deplete the hippocampus and
amygdala of AChE,

suggesting that the cholinergic medial

septal projections as well as the basoamygdaloid cholinergic
pathways were not damaged by SAP lesions of the cholinergic

NBM.
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Acetylch ol i nesterase

SAP

Control
Figure 8.

Differences in Acetylcholinesterase-Positive

Staining Observed Between the Cortices of Rats in the

Control

(A, C, and E) and Nucleus Basalis Magnocellularis

Lesion Groups

(B, D, and F). Note the Depletion of

Acetylcholinesterase Throughout the Cortex of the Nucleus
Basalis Magnocellularis Lesion Brain. Brains From the

NucleussBMagiocellularis Lesion Group Showed a Loss of
Acetylcholinesterase-Positive Fibers and Cell Bodies in the

Vicinity of the Nucleus Basalis Magnocellularis Whereas No
Such Loss Was Found in Control Brains.
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CHAPTER SEVEN
DISCUSSION

Introduction
Lesions of the NBM spared acquisition of the original

discrimination, impaired subsequent reversal performance,
and caused prolonged extinction as hypothesized.

During

acquisition, the NBM lesion and control groups did not

differ on the number of errors committed or on the number of

days required to reach criterion.

The sparing of

performance in the original discrimination,

a simple

association learning task where response contingencies do

not change

(see Pearce & Wilson,

Sutherland & Rudy,

1990; Rescorla,

1972;

1989), suggests that the NBM is not

necessary for learning in situations where demands on
cognitive flexibility are minimal.

In contrast, on the

first reversal during serial reversal training, the NBM

lesion group required more days and committed more errors in
reaching criterion compared to the control group.

Despite

this initial impairment, the NBM lesion group demonstrated
recovery on subsequent reversals.

Impaired reversal

performance in the NBM lesion group is argued to result from
perseveration on the originally correct discriminative

stimulus, where this perseveration is believed to reflect
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and underlying impairment in cognitive flexibility.

During

extinction, the NBM lesion group made more total responses
and extinguished responding more slowly than the control

group.

The greater resistance to extinction observed in the

NBM lesion group is similarly argued to reflect cognitive
inflexibility expressed as perseveration on the previously
reinforced discriminative stimuli.

Acquisition
Results supported the hypothesis that SAP lesions of

the cholinergic neurons of the NBM would spare acquisition
of original discrimination (T+, L-) .
f

The NBM lesion group

learned to selectively respond to the reinforced stimulus as
well as controls.

These results are consistent with earlier

findings of intact simple association learning in rats with

SAP lesions of the NBM (Butt & Bowman, 2002; Butt & Hodge,
1997; Butt, Schultz, Arnold, Garman, George & Garraghty,

2003).

In these previous studies, as well as in the

acquisition phase of the current experiment, the contingency
between discriminative cues and the availability

reinforcement was unambiguous and unchanging.

Moreover,

these tasks do not require sustained (see McGaughy et al.,

1999; McGaughy & Sarter, 1998) or divided attention
Turchi & Sarter,

1997; Waite et al.,
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(see

1999), nor do they tax

cognitive'flexibility.

It is argued that NBM lesions did

not affect performance in the original discrimination in the
present experiment specifically because this task does not
place significant demands on attention or require cognitive

flexibility.

Serial Reversal

When confronted with subsequent reversals of the
original discrimination, performance in the NBM lesion group

was impaired relative to the controls as hypothesized.

The

NBM lesion group committed more errors and required more

days to reach criterion than controls on the first reversal.
Although the NBM lesion group was impaired on the first

reversal, their performance recovered and groups did not
differ on subsequent reversals.

Additionally, it was

hypothesized that on both the errors and days to criterion

performance measures, there would be an interaction between
group and reversal number.

Specifically, the control group

but not the NBM lesion group was expected to show
progressively fewer errors and require fewer days to reach
criterion across successive reversals.

There was a

significant interaction between group and.reversal number on
both the days, to criterion and errors to criterion measures,

although the pattern of this interaction was not consistent
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with the hypothesis.

It was hypothesized .that the control

group would show- progressive improvement

(i.e., fewer days

to reach criterion, and fewer errors prior to reaching

criterion)

across successive reversals, while the NBM lesion

group was not expected to show such improvement.

Instead,

both groups improved across successive reversals, with the

NBM lesion group showing substantial impairments on the

first reversal followed by a rapid recovery in performance.

Performance in the NBM lesion group suffered only when
reinforcement contingencies were reversed following the

unimpaired acquisition of the original discrimination.

Animals in the NBM lesion group learned to discriminate
between the reinforced and a non-reinforced stimuli
normally, but when the reinforcement contingencies were

reversed, animals in the NBM lesion group perseverated on
the previously correct stimulus despite nonreinforcement
under the new (reversed)

control group,

reinforcement contingencies.

The

in contrast, adapted their responding to

these changing response contingencies more readily than the

NBM lesion group and showed comparatively little
perseveration across serial reversals of the original

discrimination.

These data suggest that NBM lesions disrupt

the ability to efficiently switch between conflicting ,
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response rules, while sparing the ability to discriminate
between stimuli in general.

The observation of behavioral recovery during the later

phases of serial reversal training in the current experiment
in the NBM lesion group may potentially reflect compensation

by other neurotransmitter or neuromodulatory systems in

these brain damaged animals.

An alternative interpretation

of the observed behavioral recovery in the NBM lesion group
might be that while the first reversal was sufficiently

challenging, subsequent reversals did not tax cognitive

mechanisms enough to reveal NBM lesion-induced impairments.
As normal animals progress through serial reversals, their

performance typically continues to improve with each

subsequent reversal

Wynne, 2002).

(e.g., Bailey et al.,

2003; Bonney &

In the current experiment, however, control

animals appeared to reach asymptotic floor levels of

performance as early as the second reversal, suggesting that

the cognitive demands of serial reversal may have been
comparatively low in this task.

Consequently, while the NBM

lesion group was impaired on the first reversal, cognitive
demands in the task may have been insufficient to reveal

further lesion-induced impairments as the NBM lesion group
achieved performance levels equivalent to controls by the
second reversal.

Nevertheless, the behavioral impairments
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observed in the NBM lesion group when reinforcement
contingencies were first reversed demonstrate NBM

involvement in inhibiting perseveration during serial

reversal learning, and suggest NBM involvement in cognitive
flexibility in general.

Extinction

The hypothesis that the NBM lesion group would

extinguish responding more slowly than controls was
supported.

NBM lesions caused response perseveration under

conditions of extinction, despite the fact that the NBM

lesion group had previously demonstrated behavioral recovery

during the later phases of serial reversal training.

When

the contingencies changed to the non-reinforced conditions
of extinction, the NBM lesion group continued to respond to

the discriminative stimuli longer than controls.

This

evidence of perseverative responding during extinction is

attributed to an NBM-lesion induced difficulty in modifying
behavior in response to changes in reinforcement
contingencies.

Both the perseverative responding observed during

extinction,

and the perseveration observed during serial

reversal training, are argued to reflect a common underlying

impairment in cognitive flexibility.
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Together, these

results strengthen the argument that the cholinergic NBM is

normally involved in mediating response inhibition (i.e.,
prevents perseveration), and is involved in cognitive
flexibility more generally.

The prolonged extinction and perseveration observed

following NBM lesions in the current study are similar to
findings from previous studies using pharmacological
manipulations of the cholinergic system.

(1983)

For example, Mason

found that rats treated with the'anticholinergic

muscarinic receptor antagonist scopolamine showed greater

resistance to extinction (i.e., greater perseveration)

operant discrimination than saline treated controls.

in an

The

perseveration caused by the scopolamine-induced compromise

in cholinergic function mirrors the effects observed

following NBM lesions in the current experiment.
Conversely,

treatment with the cholinergic agonist

physostigmine

(an AChE-inhibitor)

in the Mason

(1983)

study

resulted.in accelerated extinction (i.e., decreased
perseveration)

compared to saline treated controls.

These

data suggest that cholinergic activity is a critical
component of learning to withhold responding during

extinction conditions.

Together these pharmacological data

clearly demonstrate cholinergic involvement in mediating

response inhibition during extinction,
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an interpretation

consistent with the findings from the current NBM lesion

study.

Conclusion
To summarize,

selective SAP lesions of the NBM spared

acquisition of the original discrimination as predicted.
This result demonstrates the lack of NBM involvement in

simple association learning, where demands on attention are
low and where cognitive flexibility is not required to solve
the task.

In contrast, NBM lesions caused perseveration and

disrupted cognitive flexibility during serial reversal

discrimination learning;

During extinction trials following

serial reversal training, NBM lesions also led to -

perseveration, where this perseveration is argued to reflect
cognitive inflexibility.
Cognitive flexibility has been defined as the ability
to adapt to changing response rules,

shift cognitive set, or

to shift attention in order to respond to situations in

different ways

(Eslinger & Grattan,

1993; Rende, 2000).

Previous animal research suggests that damaging the NBM
causes impairments in many of these' abilities.

For example,

selective SAP lesions of the NBM cause impairments in
divided attention (Turchi & Sarter, 1997; Waite et al.,
1999), configural association learning (Butt & Bowman, 2002;
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Butt et al.,

2002; Butt et al., 2003),

learning set

.formation, and strategy switching (Bailey et al.,

2003).

It

is possible that the impaired performance observed in the
wide variety of.behavioral paradigms used to assess these

various abilities reflects a common underlying impairment in
cognitive flexibility.

Results from the current experiment

similarly can be interpreted as reflecting an NBM lesion-

induced impairment in cognitive flexibility.

The NBM may participate in cognitive flexibility
through its influence on the medial prefrontal cortex; this

brain region receives extensive cholinergic projections from

the NBM (Mayo et al.,

1984). Cholinergic activity in the

medial prefrontal cortex is critical for normal performance
in attention demanding tasks

et al.,

1997; Sarter et al.,

(McGaughy et al.,

2002; Sarter

1999), and is involved in tasks

requiring cognitive flexibility (e.g., Ragozzino, Wilcox,

Raso,

& Kesner, 1999) .

For example, previous research has

shown that temporary inactivation by tetracaine of specific

subregions of the medial prefrontal cortex impaired learning
when rats were switched .from a spatial to a visually-cued

version in a spatial learning task but not when animals were
tested in either version of the task alone

al., 1999).
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(Ragozzino et

Wise and colleagues

(1996)

argue that the medial

prefrontal cortex is involved in learning new behaviorguiding rules and in rejecting previously acquired but

currently invalid rules.

These authors propose that

reversal learning and shifting between perceptual dimensions
or strategies are mediated by the prefrontal cortex

Murray,

& Gerfen,

therefore,

1996) .

(Wise,

The medial prefrontal cortex,

appears to be involved in a wide variety of

behavioral tasks requiring cognitive flexibility.
The impaired serial reversal discrimination learning

and prolonged extinction observed in the current study may
have been caused by the cholinergic demodulation of the

prefrontal cortex which results from damage to the NBM.
Other research has shown that damaging only the cholinergic

projections to the prefrontal cortex impairs the ability to
form complex, or configural associations

(Mayo et al.,

1984), where configural association learning itself

critically depends on cognitive flexibility (see Butt &
Bowman, 2002) .

Cholinergic modulation of the medial

prefrontal cortex may therefore represent a critical neural

substrate supporting cognitive flexibility in general.

The current findings clearly indicate that NBM
cholinergic modulation of neural activity in the neocortex

is critically involved in cognitive flexibility.
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A fuller

understanding of the neural substrates for this high level
cognitive function will, of course,

amount of further research.

require a considerable

For example, future research

might examine the specific functions of cholinergic
modulation of discrete cortical regions, including the
medial prefrontal cortex, by selectively targeting only
those NBM neurons projecting to such discrete cortical areas
using emerging lesion methodologies.

Our understanding of

the role played by ACh released into the neocortex by the
NBM in learning, memory, and cognition might also benefit by

considering potential impairments in behavior,

as well as

behaviors unaffected by NBM lesions, in light of the

relative demands placed on cognitive flexibility by the

behavioral task at hand.

It is argued here that only those

tasks placing sufficient demands on cognitive flexibility

will be sensitive to selective SAP NBM lesion effects, while
behavior in less demanding tasks can be expected to spared
following these lesions.
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